London Stock Exchange welcomes LungLife AI

London Stock Exchange welcomes LungLife AI, Inc. to trading on AIM. In July 2021 LungLife successfully raised gross proceeds of £17 million and the Company’s market capitalisation on admission was £45 million with a free float of 50.6%. 

LungLife AI’s mission is to make a significant impact in the early detection of lung cancer. The Company is a developer of blood-based clinical diagnostic solutions for lung cancer enhanced by artificial intelligence, and intends to build a deep, novel pool of lung cancer-related data for AI-enabled applications designed to improve its diagnostic solutions over time.

The Company’s core technologies are integrated in the LungLB® test, which is intended to be used as a tool to provide physicians with additional information to help in the decision-making process for people with indeterminate lung nodules that may be lung cancer following a CT scan. There are estimated to be over 1.5 million individuals with indeterminate lung nodules diagnosed each year in the United States. The LungLB® test may have additional utilities, the most significant of which is likely to be in monitoring individuals for recurrence following surgical removal of cancerous lung nodules.

The Company has completed a 149 subject pilot study to evaluate the LungLB® test, which showed well-balanced performance and a Positive Predictive Value of 89 per cent. The Company is now gearing up to proceed to a larger, multi-centre validation study to garner regulatory and reimbursement support and facilitate commercialisation.

To support development of the LungLB® technology and its product pipeline, the Company has entered into various agreements with the Icahn School of Medicine at Mount Sinai (“Mount Sinai”), which is an international leader in medical and scientific training and biomedical research and is part of the Mount Sinai Health System. Mount Sinai is committed to building a world-renowned lung cancer programme with expertise in screening, early detection and biomarker research and has recently established its Center of Excellence for Thoracic Oncology programme.

Quick facts

Market: AIM
Instrument market cap (£m)
Listing/Admission to trading
08 Jul 2021

Paul Pagano, Chief Executive Officer of LungLife, said: “We are delighted with the strong support shown by new institutional investors for our fundraise and we are very proud to complete our admission to AIM, which is a key milestone in the advancement of our AI-enabled LungLB® test for early lung cancer detection.

“Lung cancer accounts for nearly a quarter of all cancer-related deaths in the US because in many cases it’s diagnosed too late. Early detection is key and we believe our simple blood test enhanced by artificial intelligence will give physicians the additional information needed to identify this disease earlier and reduce its impact."

“Our focus now is to proceed to a larger multi-centre pivotal validation study and secure regulatory authorisation and reimbursement support. We look forward to updating investors as we hit these milestones.”

Looking for new and recent issues?

More recent

London Stock Exchange welcomes Petershill Partners plc to the Premium Segment of the Main Market

Today, Petershill Partners, a leading global GP solutions investment group, begins trading on the Main Market of London Stock Exchange. Petershill Partners comprises minority investments in 19 high-quality Partner-firms, previously held in private funds managed by Goldman Sachs Asset Management (GSAM). The Partner-firms have US$187 billion of aggregated assets under m

Learn more
London Stock Exchange welcomes the UK Government’s Inaugural Green Gilt to the Sustainable Bond Market

Today, HM Treasury and the UK Debt Management Office celebrated the listing of its inaugural green gilt, marking the launch of the UK Government’s Green Financing programme. The issuance raised £10bn for a 12-year green gilt, the largest inaugural sovereign issuance to date.  Today, the green gilt is listed on London Stock Exchange’s Sustainable Bond Market.

The UK will be f

Learn more
London Stock Exchange Group welcomes City Giving Day celebrating volunteering and philanthropy in the City of London

City Giving Day is The Lord Mayor’s Appeal’s annual celebration of philanthropy and giving which provides City organisations with an opportunity to reflect on everything they do to support their local communities and charities.

Championed by successive Lord Mayors of the City of London, City Giving Day has gone from strength to strength with a record 500 companies taking part this yea

Learn more
London International Shipping Week 2021

London International Shipping Week 2021 (LISW21) is seen throughout the world as the ‘must attend’ international maritime event of the year. London is the historic centre of global trade and world shipping and stands at the heart of international commerce. Its long-standing maritime institutions have been servicing the global shipping industry for centuries and that role co

Learn more